Pancreatic cancer screening: state of the art
- 1 February 2009
- journal article
- review article
- Published by Informa UK Limited in Expert Review of Gastroenterology & Hepatology
- Vol. 3 (1), 89-96
- https://doi.org/10.1586/17474124.3.1.89
Abstract
Pancreatic cancer is a devastating disease with a median survival of approximately 6 months after diagnosis. Many factors are associated with a worse outcome; examples include late diagnosis, low resection rate, aggressive tumor behavior and a lack of an effective chemotherapy regimen. Owing to the low prevalence of pancreatic cancer relative to the diagnostic accuracy of present detection methods and the absence of promising treatment modalities, even in early stages, it is currently neither advisable nor cost effective to screen the general population. Efforts are focused on early screening of selected high-risk-cohorts, who account for approximately 10% of patients with pancreatic cancer. These include patients with chronic pancreatitis, individuals with a family history of pancreatic cancer, patients with hereditary pancreatitis, Peutz-Jeghers syndrome, cystic fibrosis or familial atypical multiple mole melanoma. At present, a multimodal-screening approach of endoscopic ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography appears to be the most effective method to screen for pancreatic cancer in high-risk patients. Continued efforts are needed to elucidate effective testing to identify patients with nonhereditary risk factors who will benefit from screening protocols. A combined approach of serum markers, genetic markers and specific imaging studies may prove to be the future of pancreatic screening.Keywords
This publication has 70 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Clinical importance of precursor lesions in the pancreasJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Long-Term Survival after Radical Resection for Pancreatic Head and Ampullary Cancer: A Potential Role for the EGF-RDigestive Surgery, 2007
- DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreasCarcinogenesis: Integrative Cancer Research, 2006
- The value of imaging techniques in the staging of pancreatic cancerSurgical Endoscopy, 2004
- Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancerAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- CDKN2A Germline Mutations in Familial Pancreatic CancerAnnals of Surgery, 2002
- Risk factors for complications after performance of ERCPGastrointestinal Endoscopy, 2002
- Screening and surveillance for hereditary pancreatic cancerGastrointestinal Endoscopy, 2002
- Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndromeInternational Journal of Cancer, 1995